Health Trials

Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants

ConditionPrematurity; Extreme
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age7-5
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

About this trial

Pulmonary vascular disease and cardiac performance in extreme preterm infants: A prospective cross-sectional study

Eligibility criteria

Qualifiers

Infants born at <29 weeks' gestational age admitted to the NICU

All infants born at <29 weeks' gestational age followed at MCH clinic after an admission in the NICU for prematurity <29 weeks

Disqualifiers

Congenital heart disease (except an atrial (ASD) or ventricular septal defect (VSD), or a patent ductus arteriosus (PDA))

Congenital severe lung or airway malformation (choanal atresia, trachea-esophageal fistula or congenital pulmonary airway malformation)

Genetic disorder (Trisomy 21).

Trial design

Treatments tested in this trial

  • Echocardiography

Treatment groups

150 Participants
are divided into 3 treatment groups

Sponsors and collaborators

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead sponsor

Source ClinicalTrials.gov